XY Sex Selection Technologies and Services
XY Inc. Home About UsSex Selection ProcedureTechnology and ServicesHistoryNews
     

 

Press Releases

Contact:
Dr. Mervyn Jacobson, 970/491-4764
or ISIS Public Relations, 970/229-0972

XY INC. CEO NAMED TO SCIENTIFIC ADVISORY BOARD IN CHINA

FORT COLLINS—A leading corporation that works to strengthen the dairy industry in China has appointed Dr. Mervyn Jacobson, CEO and president of Colorado-based XY Inc., to a top post on its scientific advisory board.

The announcement is the latest recognition of Jacobson’s international work with biotechnology businesses including XY Inc., the world leader in the research, development and commercialization of sex-selection techniques in non-human mammals, including cattle, horses, pigs and endangered species.

The Chinese National Animal Breeding Stock Export/Import Corporation (CABS), based in Beijing, named Jacobson the chief technology officer of its scientific advisory board June 30. CABS is a leading Chinese corporation that seeks to improve the health and efficiency of livestock production in China. One of the corporation’s current priorities is to build the quality of the genetics of the dairy herd in China and to introduce modern breeding techniques that will improve the quantity and quality of the dairy herd and, in turn, substantially increase milk production.

CABS also is involved with feed materials, feed additives, animal medicines and breeding poultry and companion animals. It has established business relationships with more than 60 countries and posts annual sales of more than $300 million.

Jacobson, a former clinician who got his start in the biotechnology industry in the late 1980s, will continue to head XY Inc., founded in 1996. A graduate of the University of Melbourne Medical School, he is recognized worldwide as a leader in developing new, technology-based businesses in the fields of biotechnology and advanced genetics, with special relevance to medical and veterinary applications.

He is a consultant to the University of Zurich’s Research for the Horse program; founder of GeneType AG, a Swiss-based genetic research company; and executive chairman of Genetic Technologies Limited, a public company on the Australian Stock Exchange. Last year, he was honored by colleagues in Australia when the Royal Zoological Society of South Australia voted unanimously to appoint him an Honorary Research Associate. The society cited Jacobson’s XY Inc.’s “significant role in applying sperm-sorting technology to the captive management and conservation of several exotic and locally threatened species.”